MIF may be a legitimate therapeutic goal in genitourinary malignancies; inhibiting MIF-mediated pathways that specifically boost tumorigenesis or those who increase immunotherapy could be clinically useful. Curiously, https://harleyoqpe436051.blogsmine.com/profile